Prosonix is an acknowledged leader in providing proprietary sonocrystallization solutions that deliver large scale added value benefits to our customers.

Prosonix sonocrystallization technology facilitates the Complete Crystallization Control ™ of many aspects of crystallization processes including control of crystal size, habit, size distribution and the selective production of polymorphs. Its industrial application facilitates higher productivity, enhanced filtration, reduced processing time, higher purity, and maximises yield. Our proprietary equipment is ATEX certified and is used in a variety of pharmaceutical manufacturing environments.

Prosonix award winning unique CrystalGEM ™ predictive crystallization technology service significantly enhances crystallization screening productivity across the pharmaceutical life cycle. CrystalGEM ™ is used widely by major and emerging pharmaceutical companies alike

Prosonix proprietary SAX ™ technology, is a new and exciting emergent technology for the single step production of nanoscale crystalline API materials, suitable for inhaled therapeutics.
 
Home | About Us | News | Technology | Markets | Contact Us